1. Home
  2. CELH vs STVN Comparison

CELH vs STVN Comparison

Compare CELH & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Celsius Holdings Inc.

CELH

Celsius Holdings Inc.

N/A

Current Price

$27.84

Market Cap

6.9B

ML Signal

N/A

Logo Stevanato Group S.p.A.

STVN

Stevanato Group S.p.A.

N/A

Current Price

$19.42

Market Cap

5.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
CELH
STVN
Founded
2004
1949
Country
United States
Italy
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Containers/Packaging
Sector
Consumer Staples
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
5.7B
IPO Year
2008
2021

Fundamental Metrics

Financial Performance
Metric
CELH
STVN
Price
$27.84
$19.42
Analyst Decision
Buy
Buy
Analyst Count
24
14
Target Price
★ $42.19
$24.47
AVG Volume (30 Days)
★ 5.8M
316.8K
Earning Date
11-05-2026
11-05-2026
Dividend Yield
N/A
★ 0.33%
EPS Growth
N/A
★ N/A
EPS
★ 0.47
N/A
Revenue
★ $1,318,014,000.00
N/A
Revenue This Year
$26.05
$7.05
Revenue Next Year
$8.51
$9.23
P/E Ratio
$58.30
★ $27.15
Revenue Growth
★ 101.65
N/A
52 Week Low
$23.56
$12.89
52 Week High
$66.74
$27.99

Technical Indicators

Market Signals
Indicator
CELH
STVN
Relative Strength Index (RSI) 45.27 34.99
Support Level $27.23 $18.87
Resistance Level $30.19 $20.63
Average True Range (ATR) 0.98 0.78
MACD 0.01 -0.26
Stochastic Oscillator 32.58 14.04

Price Performance

Historical Comparison
CELH
STVN

About CELH Celsius Holdings Inc.

Celsius Holdings operates in the energy drink subsegment of the global nonalcoholic beverage market, with 95% of revenue concentrated in North America. It owns three energy drink brands: Celsius, Alani Nu, and Rockstar Energy. It focuses on product innovation and marketing while outsourcing manufacturing and packaging to third-party co-packers and distribution to PepsiCo. The firm issued convertible preferred shares following PepsiCo's investments in 2022 and 2025, giving the latter an 11% stake in Celsius.

About STVN Stevanato Group S.p.A.

Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.

Share on Social Networks: